Clinipace Blog

Clinipace Expert Discusses Benefit of Standardized Data

The benefits of standardized data are well known — it improves communication; it makes better use of time and resources; it facilitates comparison; it adds transparency; it enhances data sharing and collaborators among scientists, studies and companies; and it eases...

read more

EU Data Privacy in 2017: What You Need to Know

Webcast presentation on Thursday, April 6th, 2017 @ 11:30am ET In 2016, the European Union (EU) approved new harmonized privacy regulations, known as the General Data Protection Regulations (GDPR). The GDPR will impose greater obligations on companies established in...

read more

Visit Clinipace at the DGPharMed 33rd Annual Congress

The Clinipace Worldwide team from Germany is looking forward to connecting with friends and colleagues at the upcoming 33rd Annual DGPharMed Conference/Congress in Berlin. The event, coming up this week from March 23rd – 24th is titled, “Drug and product development tomorrow: Striking new paths?”

read more

Clinipace Exhibits @ Partnerships in Clinical Trials

Will you be attending Partnerships in Clinical Trials in Vienna on November 16th and 17th? The theme for the event is “Accelerate Clinical Development and Improve Trial Quality by Benchmarking and Enhancing Clinical Practices and Partnering,” and who knows how to accelerate clinical development and improve trial quality, better than a digital CRO?

read more

Clinipace Stats Experts Answer Questions at PhUSE 2016

Our team at Clinipace Worldwide is looking forward to exhibiting at the upcoming PhUSE 2016 conference in Barcelona. The focus of this year’s conference will be around how to standardize and design trials and utilize data more effectively to reduce the time to...

read more

Clinipace Team Talks Innovation in Cancer Therapy at ASCO 2016

Last week, we spent time with some of the best and brightest minds in oncology at ASCO 2016 in Chicago. Speaking with so many professionals who are passionately advancing new therapies is a privilege and motivates our team to work even harder with our sponsors to develop the new treatments that are significantly improving the outcomes for patients.

read more

Understanding FDA’s Final Guidance on Exempt Infant Formula Production

Marci Ardinger is the Associate Director of Project Management at Clinipace Worldwide. Infant formulas play an important role in the overall health of infants that consume them, and the FDA has recognized that infant formulas for specific uses (i.e., infants with inborn errors of metabolism, low birth weight and other medical or dietary issues) might need

read more

Clinipace Statistical Expert Presenting at 5th Annual PhUSE and FDA Collaboration Computational Science Symposium (CSS)

Dirk Spruck, Clinipace’s Manager of Statistical Programming, will share his expertise as part of a working group during the 5th annual Computational Science Symposium (CSS) held by PhUSE and the FDA March 13 – 15, 2016 in Silver Spring, Maryland. Dirk and his collaborators, Hanming Tu of Accenture and Dante Di Tommaso of Roche, will present on behalf of

read more

Clinical Events Adjudication in the Digital Age: The CEC Process

Thank you to everyone who attended our webcast “Clinical Events Adjudication in the Digital Age.” In the presentation, we discussed when clinical events committees (CECs) are needed, CEC structures, CEC processes, what to look for when outsourcing CEC services and benefits of technology-enabled CEC processes.

read more

Clinical Events Adjudication in the Digital Age: CEC Structure

Thank you to everyone who attended our webcast “Clinical Events Adjudication in the Digital Age.” In the presentation, we discussed when clinical events committees (CECs) are needed, CEC structures, CEC processes, what to look for when outsourcing CEC services and benefits of technology-enabled CEC processes.

read more